Elena Grovetti
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Efficacy of complement inhibition with pegcetacoplan in children with C3 glomerulopathy.
Journal: Pediatric nephrology (Berlin, Germany)
Published: August 28, 2024
Involvement of the contact pathway in COVID-19 coagulopathy.
Journal: Internal and emergency medicine
Published: August 27, 2024
Contact System Activation and Bradykinin Generation in Patients With Idiopathic Angioedema.
Journal: Journal of investigational allergology & clinical immunology
Published: February 21, 2024
Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition.
Journal: Journal of nephrology
Published: August 10, 2023
Effects of Antibody Responses to Pre-Existing Coronaviruses on Disease Severity and Complement Activation in COVID-19 Patients.
Journal: Microorganisms
Published: May 02, 2022
Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination.
Journal: Journal of autoimmunity
Published: August 19, 2021
Eculizumab treatment in atypical hemolytic uremic syndrome: correlation between functional complement tests and drug levels.
Journal: Journal of nephrology
Published: May 12, 2021
Corrigendum to "Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19" [J. Autoimmun. 117C (2020) 102595].
Journal: Journal of autoimmunity
Published: May 03, 2021
Kidney transplant in patients with atypical hemolytic uremic syndrome in the anti-C5 era: single-center experience with tailored Eculizumab.
Journal: Journal of nephrology
Published: January 15, 2021
Chromosome 3 cluster rs11385942 variant links complement activation with severe COVID-19.
Journal: Journal of autoimmunity
Published: November 20, 2020
Last Updated: 09/26/2026